PREMIO Vitamin K2+ D3
MenaQ7® and D3 work together to maintain bone and cardiovascular health. MenaQ7® is vitamin K2 (MK-7), the most absorbable, bioactive, long-lasting form of vitamin K. The only proven, patented vitamin K2 isomer (over 20 clinical studies) that, in combination with vitamin D3, directs calcium to bone (cooperatively controlling the function of normal bone mineralization proteins such as osteocalcin, etc.). MenaQ7® + D3 thus increases the body’s ability to use the substances necessary for bone building (calcium, building proteins: bone health), while MenaQ7® simultaneously prevents the accumulation of calcium (activates the proteins that prevent it) in soft tissues and arterial walls (cardiovascular health).
Based on scientific and clinical studies, this product is suitable for the following problems:
- bone health
- problems with blood clotting (easily developing long-term bruising on the body)
- reduced arterial elasticity, symptoms of aortic stenosis.
- diagnosed prediabetes
MenaQ7® is a registered trademark owned by Lesaffre.
Vitashine D3® is a registered trademark owned by ESB Developments Ltd.
MenaQ7® is the only clinically validated, patented form of vitamin K2 (MK-7) that is among the top preparations available today.
Randomized Controlled Trial - Prevention of bone loss: Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int, Knapen et al., 2013.
Multicenter Randomized Controlled Trial – Chronic hemodialysis and diabetic patients: Effect of Menaquinone-7 Supplementation on Arterial Stiffness in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial. Nutrients, Naiyarakseree et al., 2023.
Clinical trial, cardiovascular, arteries: Effect of Menaquinone-7 (vitamin K2) on vascular elasticity in healthy subjects: results from a one-year study. Vascular Diseases and Therapeutics, Vermeer, Hik, 2020.
Cardiovascular health, diabetes: Vitamin K2—a neglected player in cardiovascular health: a narrative review. Open Heart (BMJ Journals), Hariri et al., 2021
| Netto amount | 30ml |
|---|---|
| Ingredients | MenaQ7®K2 (naturally produced menaquinone-7,) Vitashine D3® (cholecalciferol,) MCT coconut oil. |
| Daily dose (1ml) contains | 200 µg K2 (*267%,) 20 µg D3 (*400%.) *% NRV – Percentage of reference daily intake in adults. |
| Recommended maximum daily amount | over 18 years: 1ml; 11-18 years 0,5ml; 1-11 years 0,25ml; Use the measuring scale on the pipette. At the maximum recommended amount, the bottle contains 30 doses. Consume with fattier breakfast. |
| Warnings | Do not exceed the daily amount. Keep the product out of the reach of children. Store at room temperature in the original container away from moisture and light, refrigerate after opening. Do not use as a substitute for a varied diet. It is important to eat a varied and balanced diet and to lead a healthy lifestyle. Users of medicines (blood thinners, especially Varfarin) should consult a doctor. |
| Producer/Distributor | Produced in Norway (1440 Drøbak) by |
Related products
